,pert_name,Cluster,MOA,Less than 20% Viable,Less than 30% Viable
2428,funapide,0,SODIUM CHANNEL BLOCKER,1.0,5.0
3237,lifitegrast,0,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,1.0,6.0
2320,fk-409,0,GUANYLYL CYCLASE ACTIVATOR,3.0,5.0
552,argireline,0,NEUROTRANSMITTER RELEASE INHIBITOR,2.0,5.0
5918,vatinoxan,0,ADRENERGIC RECEPTOR ANTAGONIST,0.0,2.0
1268,celgosivir,1,GLUCOSIDASE INHIBITOR,1.0,4.0
880,bfh772,1,VEGFR INHIBITOR,16.0,63.0
2637,gsk3326595,1,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,87.0,181.0
5198,sobuzoxane,1,TOPOISOMERASE INHIBITOR,4.0,11.0
5232,sp-100030,1,NFKB PATHWAY INHIBITOR,11.0,28.0
4266,pdd-00017273,1,PARG INHIBITOR,18.0,38.0
6017,w-54011,2,ANAPHYLATOXIN CHEMOTACTIC RECEPTOR ANTAGONIST,1.0,4.0
1541,cot-inhibitor-2,2,MAPK-INTERACTING KINASE INHIBITOR,7.0,18.0
4414,phikan-083,2,P53 STABILIZING AGENT,5.0,20.0
5919,vby-825,2,CATHEPSIN INHIBITOR,4.0,7.0
2183,ethoxyquin,2,ANTIOXIDANT,2.0,7.0
3659,ml141,2,GTPASE INHIBITOR,3.0,10.0
942,bms-182874,2,ENDOTHELIN RECEPTOR ANTAGONIST,8.0,16.0
1702,dasotraline,3,DOPAMINE-NOREPINEPHRINE-SEROTONIN REUPTAKE INHIBITOR,4.0,10.0
2603,gsk1562590,3,UROTENSIN RECEPTOR ANTAGONIST,4.0,8.0
2837,idh-305,4,ISOCITRATE DEHYDROGENASE INHIBITOR,0.0,4.0
4648,prx-07034,4,SEROTONIN RECEPTOR ANTAGONIST,1.0,4.0
4329,pf-04995274,4,SEROTONIN RECEPTOR AGONIST,2.0,2.0
4875,rolapitant,4,NEUROKININ RECEPTOR ANTAGONIST,1.0,3.0
4273,pelrinone,4,PHOSPHODIESTERASE INHIBITOR,1.0,2.0
890,bia-10-2474,4,FATTY ACID HYDROLASE INHIBITOR,0.0,2.0
3187,leq506,4,G PROTEIN SIGNALING INHIBITOR,0.0,3.0
5857,uk-5099,5,MONOCARBOXYLATE TRANSPORTER INHIBITOR,3.0,14.0
103,5-fluoropyrimidine,6,KINASE INHIBITOR,2.0,8.0
3647,mk-7622,6,CHOLINERGIC RECEPTOR AGONIST,3.0,6.0
1492,clonixin,6,CYCLOOXYGENASE INHIBITOR,0.0,2.0
3400,madecassoside,7,ANTI-INFLAMMATORY AGENT,0.0,3.0
6069,xl041,7,LXR AGONIST,14.0,22.0
1973,e3330,7,NFKB PATHWAY INHIBITOR,3.0,7.0
4068,ombitasvir,7,HCV INHIBITOR,1.0,6.0
969,bms-813160,7,CC CHEMOKINE RECEPTOR ANTAGONIST,1.0,3.0
2402,fostemsavir,7,ANTIVIRAL,0.0,3.0
5810,tucidinostat,8,HDAC INHIBITOR,44.0,124.0
1444,citarinostat,8,HDAC INHIBITOR,3.0,8.0
5050,sbha,8,HDAC INHIBITOR,3.0,9.0
5483,tcs-2210,8,NEURAL STEM CELL INDUCER,12.0,39.0
5461,tc-h-106,8,HDAC INHIBITOR,12.0,38.0
1610,cxd101,8,HDAC INHIBITOR,440.0,574.0
2635,gsk3117391,8,HDAC INHIBITOR,644.0,748.0
3269,lmk-235,8,HDAC INHIBITOR,88.0,225.0
5852,uf-010,8,HDAC INHIBITOR,7.0,15.0
3495,merck60,8,HDAC INHIBITOR,274.0,394.0
1003,brd9876,9,KINESIN INHIBITOR,3.0,8.0
706,azd5991,9,MCL1 INHIBITOR,236.0,308.0
400,amg-176,9,MCL1 INHIBITOR,84.0,124.0
2190,etifenin,10,RENAL FUNCTION DIAGNOSTIC AGENT,2.0,3.0
4762,remetinostat,10,HDAC INHIBITOR,2.0,3.0
595,astilbin,11,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",6.0,13.0
2058,encorafenib,12,RAF INHIBITOR,46.0,103.0
571,as-252424,12,PI3K INHIBITOR,7.0,15.0
3375,ly3214996,12,ERK INHIBITOR,109.0,176.0
2718,her2-inhibitor-1,13,EGFR INHIBITOR,3.0,13.0
3888,nifedipine,13,CALCIUM CHANNEL BLOCKER,1.0,13.0
5900,valbenazine,13,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,1.0,5.0
4801,riboflavin-tetrabutyrate,14,ANTIOXIDANT,5.0,7.0
5095,segesterone-acetate,14,PROGESTERONE RECEPTOR AGONIST,3.0,6.0
110,5-octanoylsalicylic-acid,14,PROTEIN KINASE ACTIVATOR,1.0,3.0
1533,cort-108297,14,GLUCOCORTICOID RECEPTOR ANTAGONIST,2.0,6.0
3398,macitentan-n-butyl-analogue,14,ENDOTHELIN RECEPTOR ANTAGONIST,0.0,4.0
1031,bromisoval,15,ANTI-INFLAMMATORY AGENT,1.0,5.0
1211,ccg-1423,15,APOPTOSIS STIMULANT,3.0,5.0
5540,tepp-46,15,PYRUVATE KINASE ISOZYME ACTIVATOR,1.0,6.0
2531,gka-50,15,GLUCOKINASE ACTIVATOR,1.0,9.0
4274,pemafibrate,15,PPAR RECEPTOR AGONIST,1.0,6.0
1496,cloperastine-fendizoate,15,POTASSIUM CHANNEL ANTAGONIST,3.0,14.0
1988,ectoine,16,ANTI-INFLAMMATORY AGENT,2.0,4.0
1747,delpazolid,16,ANTIBACTERIAL,2.0,5.0
1738,delafloxacin,16,ANTIINFECTIVE DRUG,2.0,3.0
5784,trofosfamide,16,DNA ALKYLATING AGENT,1.0,4.0
4493,pirmenol,16,ACETYLCHOLINE RECEPTOR INHIBITOR,3.0,6.0
4019,o-304,16,AMPK ACTIVATOR,1.0,5.0
5514,telratolimod,16,TOLL-LIKE RECEPTOR AGONIST,15.0,24.0
1359,chlorphenoxamine,16,HISTAMINE RECEPTOR ANTAGONIST,2.0,6.0
3650,mk-8617,16,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,1.0,2.0
3421,mavacamten,16,MYOSIN INHIBITOR,2.0,6.0
5083,sdz-220-040,17,GLUTAMATE RECEPTOR ANTAGONIST,3.0,8.0
5128,sgc-707,18,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,0.0,3.0
1942,dr-2313,18,PARP INHIBITOR,0.0,2.0
6031,way-629,18,SEROTONIN RECEPTOR AGONIST,1.0,9.0
4404,phenyl-salicylate,18,ANTISEPTIC,1.0,3.0
4946,s-3304,19,MATRIX METALLOPROTEASE INHIBITOR,1.0,3.0
3360,ly2828360,19,CANNABINOID RECEPTOR AGONIST,1.0,2.0
1271,cenicriviroc,19,CC CHEMOKINE RECEPTOR ANTAGONIST,4.0,4.0
5761,trifloxystrobin,20,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,33.0,83.0
3467,meglutol,20,HMGCR INHIBITOR,2.0,2.0
2431,furamidine,20,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,3.0,20.0
1798,dhbp,20,RYANODINE RECEPTOR BLOCKER,150.0,281.0
3909,nisoldipine,20,CALCIUM CHANNEL BLOCKER,12.0,24.0
2788,iacs-10759,20,MITOCHONDRIAL COMPLEX I INHIBITOR,147.0,276.0
1559,cp-94253,21,SEROTONIN RECEPTOR AGONIST,4.0,5.0
3015,jnj-27141491,21,CC CHEMOKINE RECEPTOR ANTAGONIST,5.0,11.0
57,"3,4-dcpg-(r)",21,GLUTAMATE RECEPTOR ANTAGONIST,1.0,6.0
3363,ly288513,21,CCK RECEPTOR ANTAGONIST,5.0,9.0
3272,lodenosine,21,ANTIRETROVIRAL,1.0,2.0
784,bay-60-7550,21,PHOSPHODIESTERASE INHIBITOR,3.0,9.0
3991,ntrc-824,22,NEUROTENSIN RECEPTOR ANTAGONIST,1.0,6.0
4557,pralmorelin,22,GROWTH HORMONE RELEASING PEPTIDE LIGAND AGONIST,2.0,8.0
820,bendazol,22,NITRIC OXIDE SYNTHASE STIMULANT,2.0,6.0
1745,delgocitinib,22,JAK INHIBITOR,1.0,4.0
4842,rn-1,23,HISTONE DEMETHYLASE INHIBITOR,2.0,7.0
2598,gsk-lsd-1,23,HISTONE LYSINE DEMETHYLASE INHIBITOR,3.0,11.0
3922,nk-252,24,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",7.0,14.0
4263,pd-81723,24,ADENOSINE RECEPTOR AGONIST,0.0,4.0
5370,t-025,24,CLK INHIBITOR,3.0,8.0
4027,ocaperidone,24,SEROTONIN RECEPTOR ANTAGONIST,2.0,5.0
5482,tcs-21311,25,JAK INHIBITOR,74.0,135.0
2496,geldanamycin,25,HSP INHIBITOR,852.0,875.0
5265,sr-3677,25,RHO ASSOCIATED KINASE INHIBITOR,7.0,25.0
3732,mps1-in-5,25,PROTEIN KINASE INHIBITOR,270.0,420.0
792,bay1217389,25,KINASE INHIBITOR,394.0,552.0
671,azaguanine-8,25,PURINE ANTAGONIST,235.0,349.0
2836,idf-11774,25,HYPOXIA INDUCIBLE FACTOR INHIBITOR,0.0,2.0
1296,cfi-402257,25,DUAL SPECIFICITY PROTEIN KINASE INHIBITOR,368.0,522.0
993,bos-172722,25,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,311.0,471.0
3730,mps-bay-2a,25,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,369.0,526.0
1719,debio-0932,25,HSP INHIBITOR,823.0,867.0
5714,tp-3654,26,"1,4,5-TRISPHOSPHATE INHIBITOR",9.0,20.0
797,bctc,26,TRPV ANTAGONIST,5.0,12.0
5256,sr-1078,26,RETINOID RECEPTOR AGONIST,35.0,71.0
744,bafilomycin-a1,26,ATPASE INHIBITOR,114.0,193.0
5090,seclidemstat,27,HISTONE DEMETHYLASE INHIBITOR,512.0,639.0
4958,s63845,27,MCL1 INHIBITOR,42.0,71.0
5611,threo-2-methylisocitrate-(dl),27,ISOCITRATE LYASE SUBSTRATE,188.0,285.0
2018,elacytarabine,27,ANTINEOPLASTIC AGENT,73.0,205.0
1101,bw-348u87,27,ANTIVIRAL,427.0,570.0
2212,etretinate,28,PROTEIN SYNTHESIS INHIBITOR,4.0,11.0
701,azd5069,28,CC CHEMOKINE RECEPTOR ANTAGONIST,0.0,3.0
445,ammonium-perfluorocaprylate,28,PIM KINASE INHIBITOR,4.0,8.0
5192,sng-1153,28,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),9.0,29.0
391,amd-3465,28,CC CHEMOKINE RECEPTOR ANTAGONIST,3.0,14.0
3427,mc1568,28,HDAC INHIBITOR,0.0,6.0
5062,sch-221510,29,NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST,0.0,2.0
3092,krca-0008,29,ALK INIHIBITOR,24.0,59.0
812,belizatinib,29,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,48.0,122.0
980,bms-986142,29,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,12.0,38.0
3731,mps1-in-1,29,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,18.0,38.0
975,bms-935177,29,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,8.0,33.0
953,bms-536924,29,IGF-1 INHIBITOR,163.0,279.0
3811,nas-181,30,SEROTONIN RECEPTOR ANTAGONIST,4.0,6.0
3606,miridesap,30,AMYLOID PROTEIN INHIBITOR,1.0,7.0
1013,brincidofovir,30,ANTIVIRAL,4.0,10.0
5804,ts-011,30,DELAYED VASOSPASM ANTAGONIST,1.0,6.0
1686,dapansutrile,30,ANTI-INFLAMMATORY AGENT,0.0,4.0
2128,erk5-in-1,31,MAP KINASE INHIBITOR,10.0,33.0
2787,i-cbp-112,31,BROMODOMAIN INHIBITOR,1.0,7.0
141,a-485,31,HISTONE ACETYLTRANSFERASE INHIBITOR,133.0,241.0
6076,xmd8-92,31,MAP KINASE INHIBITOR,7.0,19.0
4148,oxf-bd-02,31,BROMODOMAIN INHIBITOR,10.0,22.0
690,azd3264,31,IKK INHIBITOR,4.0,8.0
5197,soblidotin,32,MICROTUBULE INHIBITOR,746.0,815.0
3620,mivobulin,32,MICROTUBULE INHIBITOR,676.0,771.0
1584,crolibulin,32,TUBULIN POLYMERIZATION INHIBITOR,724.0,795.0
4077,on-01500,32,APOPTOSIS STIMULANT,660.0,763.0
4069,ombrabulin,32,TUBULIN POLYMERIZATION INHIBITOR,736.0,820.0
3646,mk-7246,33,CRTH RECEPTOR ANTAGONIST,0.0,4.0
4450,pim-1-inhibitor-2,33,PIM KINASE INHIBITOR,15.0,34.0
1174,cardionogen-1,33,WNT SIGNALING INHIBITOR,4.0,13.0
5639,tinazoline,33,ADRENERGIC RECEPTOR AGONIST,1.0,4.0
5987,voruciclib,33,CDK9 INHIBITOR,0.0,7.0
3125,l-755507,34,ADRENERGIC RECEPTOR AGONIST,1.0,5.0
6052,wye-687,34,MTOR INHIBITOR,604.0,763.0
6042,wortmannin,34,PI3K INHIBITOR,55.0,115.0
1206,cc-223,34,MTOR INHIBITOR,204.0,404.0
5755,triciribine-phosphate,34,AKT INHIBITOR,57.0,116.0
791,bay1125976,34,AKT INHIBITOR,24.0,57.0
2479,gdc-0077,34,PI3K INHIBITOR,18.0,45.0
2480,gdc-0084,34,"MTOR INHIBITOR, PI3K INHIBITOR",456.0,644.0
2608,gsk2110183,34,AKT INHIBITOR,18.0,48.0
2618,gsk2334470,34,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,30.0,73.0
2511,genz-123346,34,GLUCOSYLCERAMIDASE INHIBITOR,14.0,76.0
2609,gsk2110183,34,AKT INHIBITOR,18.0,48.0
2955,iso-1,35,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,3.0,7.0
4258,pd-173212,35,CALCIUM CHANNEL BLOCKER,2.0,11.0
3311,ltx-315,35,ANTICANCER AGENT,0.0,3.0
4330,pf-05089771,35,SODIUM CHANNEL BLOCKER,0.0,3.0
3666,ml218,35,T-TYPE CALCIUM CHANNEL BLOCKER,3.0,6.0
3974,ns-5806,35,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,2.0,3.0
140,a-438079,35,PURINERGIC RECEPTOR ANTAGONIST,7.0,15.0
6130,zebularine,35,DNA METHYLTRANSFERASE INHIBITOR,1.0,4.0
2612,gsk2193874,36,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,0.0,6.0
6107,ys-201,36,CALCIUM RECEPTOR ANTAGONIST,1.0,4.0
2287,ferrostatin-1,36,FERROPTOSIS INHIBITOR,4.0,7.0
2395,fosfluconazole,36,OTHER ANTIFUNGAL,2.0,2.0
3176,ldn-27219,36,TISSUE TRANSGLUTAMINASE INHIBITOR,0.0,2.0
5277,st-1535,36,ADENOSINE RECEPTOR ANTAGONIST,0.0,2.0
2792,iberdomide,37,CEREBLON MODULATOR,2.0,8.0
2556,gne-7915,37,LEUCINE RICH REPEAT KINASE INHIBITOR,0.0,2.0
5338,sulfisomidin,37,ANTIBACTERIAL,0.0,3.0
2044,emeramide,37,ANTIOXIDANT,2.0,6.0
644,avex-73,37,SIGMA RECEPTOR AGONIST,1.0,4.0
636,avadomide,37,ANTITUMOR AGENT,6.0,12.0
4367,pf-8380,38,AUTOTAXIN INHIBITOR,0.0,3.0
4827,risdiplam,38,RNA SPLICING INHIBITOR,0.0,7.0
3970,ns-1643,38,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,6.0,19.0
2807,ica-110381,38,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,2.0,8.0
674,azapropazone,38,CYCLOOXYGENASE INHIBITOR,1.0,4.0
5469,tc-o-9311,38,G PROTEIN-COUPLED RECEPTOR AGONIST,2.0,11.0
1243,cefmetazole,38,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,1.0,3.0
4942,s-07662,38,CAR ANTAGONIST,1.0,2.0
1957,dsr-6434,39,TOLL-LIKE RECEPTOR AGONIST,1.0,4.0
3863,nfkb-activation-inhibitor-ii,39,NFKB PATHWAY INHIBITOR,2.0,7.0
2989,itx3,39,GEF INHIBITOR,3.0,6.0
5032,sb-452533,39,TRPV ANTAGONIST,4.0,13.0
589,asp-6537,40,CYCLOOXYGENASE INHIBITOR,1.0,2.0
3161,larazotide-acetate,40,TIGHT JUNCTION REGULATOR,1.0,4.0
5881,uprifosbuvir,40,ANTIVIRAL,2.0,9.0
3578,mg-624,41,ACETYLCHOLINE RECEPTOR ANTAGONIST,36.0,80.0
2887,incyclinide,41,MATRIX METALLOPROTEASE INHIBITOR,19.0,50.0
1849,dim-c-pphco2me,41,NUCLEAR RECEPTOR ANTAGONIST,508.0,669.0
1729,deferasirox,41,CHELATING AGENT,1.0,13.0
1728,deferasirox,41,CHELATING AGENT,1.0,13.0
5849,uc-112,41,XIAP INHIBITOR,73.0,136.0
3545,methylbenzethonium-chloride,41,OTHER ANTIBIOTIC,64.0,125.0
754,baloxavir,41,ENDONUCLEASE INHIBITOR,113.0,229.0
4841,rmc-4550,42,SHIP2 PHOSPHATASE INHIBITOR,84.0,155.0
4241,pci-29732,42,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,24.0,72.0
3804,naquotinib,42,EGFR INHIBITOR,527.0,674.0
735,azm-475271,42,SRC INHIBITOR,31.0,79.0
5180,sklb-1028,42,"ABL KINASE INHIBITOR, EGFR INHIBITOR, FLT3 INHIBITOR",140.0,215.0
5102,selitrectinib,43,PROTEIN TYROSINE KINASE INHIBITOR,2.0,4.0
3155,lanifibranor,43,PPAR RECEPTOR AGONIST,2.0,4.0
779,bay-1436032,43,ISOCITRATE DEHYDROGENASE INHIBITOR,2.0,2.0
3165,lasofoxifene,43,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),17.0,39.0
3989,nsp-805,44,PHOSPHODIESTERASE INHIBITOR,1.0,3.0
5729,transcrocetinate,44,GLUTAMATE RECEPTOR ANTAGONIST,1.0,6.0
3315,lucanthone,44,ENDONUCLEASE INHIBITOR,11.0,16.0
1401,cilofexor,44,FXR AGONIST,0.0,3.0
2944,irganox-1010,44,ANTIOXIDANT,1.0,2.0
4513,plumbagin,44,ANTICANCER AGENT,3.0,9.0
1152,capromorelin,44,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,1.0,2.0
1724,declopramide,44,CELL CYCLE INHIBITOR,1.0,4.0
5976,voclosporin,45,CALCINEURIN INHIBITOR,7.0,17.0
3452,mecysteine,45,ANALGESIC AGENT,7.0,15.0
3049,k145,45,SPHINGOSINE KINASE INHIBITOR,13.0,30.0
371,alx-40-4c,46,CC CHEMOKINE RECEPTOR ANTAGONIST,3.0,6.0
973,bms-906024,46,GAMMA SECRETASE INHIBITOR,4.0,8.0
2174,ethanolamine-oleate,46,IMMUNOSTIMULANT,0.0,6.0
3737,mrk-560,46,GAMMA SECRETASE INHIBITOR,3.0,9.0
5096,seladelpar,46,PPAR RECEPTOR AGONIST,1.0,3.0
1576,crenigacestat,46,NOTCH SIGNALING INHIBITOR,1.0,3.0
5284,statil,46,ALDOSE REDUCTASE INHIBITOR,2.0,7.0
4785,reynoutrin,46,ANTIOXIDANT,2.0,6.0
2870,imidurea,46,OTHER ANTIBIOTIC,0.0,4.0
4893,rosuvastatin,47,HMGCR INHIBITOR,2.0,8.0
4529,polaprezinc,47,CHELATING AGENT,1.0,2.0
4894,rosuvastatin,47,HMGCR INHIBITOR,2.0,8.0
2429,furagin,47,ANTIBACTERIAL,1.0,5.0
3399,macozinone,47,DPRE1 INHIBITOR,0.0,2.0
1941,dqp-1105,47,GLUTAMATE RECEPTOR ANTAGONIST,0.0,4.0
952,bms-470539,47,MELANOCORTIN RECEPTOR AGONIST,2.0,5.0
536,aqw-051,47,NICOTINIC RECEPTOR AGONIST,11.0,29.0
5215,sograzepide,47,GASTRIN INHIBITOR,4.0,12.0
177,abt-072,47,RNA POLYMERASE INHIBITOR,1.0,5.0
4818,rimeporide,48,SODIUM/HYDROGEN EXCHANGER INHIBITOR,1.0,4.0
2793,ibiglustat,48,GLUCOSYLCERAMIDASE INHIBITOR,3.0,7.0
2214,euk-134,48,CATALASE STIMULANT,3.0,16.0
5973,vlx1570,49,DEUBIQUITINASE INHIBITOR,891.0,893.0
438,amiselimod,49,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,881.0,882.0
3038,jw-642,49,MONOACYLGLYCEROL LIPASE INHIBITOR,1.0,6.0
770,basmisanil,49,GABA RECEPTOR INVERSE AGONIST,1.0,4.0
2931,iox1,49,HISTONE DEMETHYLASE INHIBITOR,6.0,15.0
85,4-damp,49,CHOLINERGIC RECEPTOR ANTAGONIST,0.0,3.0
802,bebt-908,49,PI3K INHIBITOR,887.0,889.0
4036,of-1,50,BROMODOMAIN INHIBITOR,2.0,11.0
6040,wiskostatin,50,"ACTIN RELATED PROTEIN INHIBITOR, NEURAL WISKOTT-ALDRICH SYNDROME PROTEIN INHIBITOR",3.0,8.0
3073,khk-in-1,50,HEXOKINASE INHIBITOR,27.0,64.0
3380,ly404187,50,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,1.0,7.0
1215,cct-031374,50,WNT SIGNALING INHIBITOR,4.0,10.0
2859,imatinib,51,"BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",10.0,22.0
2858,imatinib,51,"BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",10.0,22.0
4276,pemirolast,51,MEDIATOR RELEASE INHIBITOR,2.0,4.0
4206,pantoprazole,51,ATPASE INHIBITOR,0.0,2.0
4205,pantoprazole,51,ATPASE INHIBITOR,0.0,2.0
4277,pemirolast,51,MEDIATOR RELEASE INHIBITOR,2.0,4.0
5164,sitaxentan,51,ENDOTHELIN RECEPTOR ANTAGONIST,1.0,3.0
2907,ingenol,51,PKC ACTIVATOR,1.0,3.0
5163,sitaxentan,51,ENDOTHELIN RECEPTOR ANTAGONIST,1.0,3.0
570,as-2444697,52,INTERLEUKIN INHIBITOR,17.0,30.0
4826,ripretinib,52,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,8.0,15.0
3607,mirin,52,MRE11A EXONUCLEASE INHIBITOR,1.0,3.0
142,a-582941,53,NICOTINIC RECEPTOR AGONIST,1.0,5.0
4671,putrescine,53,TISSUE TRANSGLUTAMINASE INHIBITOR,6.0,13.0
795,bc-11,53,UROKINASE INHIBITOR,10.0,14.0
2629,gsk2837808a,53,LACTATE DEHYDROGENASE INHIBITOR,1.0,6.0
4959,sa-47,53,FAAH INHIBITOR,7.0,14.0
3994,nu-2058,53,CYCLIN D INHIBITOR,1.0,5.0
2981,isx-9,53,NEURAL STEM CELL INDUCER,1.0,2.0
6028,way-316606,53,SECRETED FRIZZLED RELATED PROTEIN INHIBITOR,2.0,10.0
601,at-406,54,IAP ANTAGONIST,65.0,111.0
597,astx660,54,APOPTOSIS INHIBITOR,85.0,134.0
5184,sm-164,54,XIAP INHIBITOR,6.0,21.0
705,azd5582,54,XIAP INHIBITOR,214.0,328.0
4042,oicr-9429,54,WDR5/MLL INTERACTION INHIBITOR,0.0,3.0
5492,tcv-309,55,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,0.0,3.0
1405,ciluprevir,55,SERINE PROTEASE INHIBITOR,2.0,4.0
5385,tafluprost,55,PROSTAGLANDIN INHIBITOR,1.0,7.0
2634,gsk2982772,55,RIPK INHIBITOR,1.0,2.0
3627,mk-0608,55,ANTIVIRAL,1.0,2.0
5942,verdiperstat,55,MYELOPEROXIDASE INHIBITOR,0.0,3.0
2004,efletirizine,55,ANTIHISTAMINE,1.0,3.0
2806,ica-069673,56,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,0.0,4.0
2210,etrasimod,56,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,0.0,4.0
1767,deslorelin,56,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,1.0,5.0
4065,omadacycline,56,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,0.0,2.0
2571,gpi-688,56,GLYCOGEN PHOSPHORYLASE INHIBITOR,1.0,5.0
4751,rbc8,57,RAL GTPASE INHIBITOR,2.0,3.0
4218,parethoxycaine,57,LOCAL ANESTHETIC,1.0,6.0
3428,mcn-5652-(+/-),57,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),5.0,7.0
3557,methysergide,57,SEROTONIN RECEPTOR ANTAGONIST,0.0,3.0
4243,pco-400,57,POTASSIUM CHANNEL ACTIVATOR,1.0,3.0
5065,sch-51344,57,MTH1 INHIBITOR,2.0,14.0
1606,cw-008,57,PKA ACTIVATOR,2.0,12.0
3717,morphothiadin,57,ANTIINFECTIVE DRUG,1.0,2.0
5283,stat3-inhibitor-vi,57,STAT INHIBITOR,2.0,4.0
5350,sultopride,57,DOPAMINE RECEPTOR ANTAGONIST,3.0,5.0
6005,vu152100,58,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,0.0,2.0
5086,sdz-ser-082,58,SEROTONIN RECEPTOR ANTAGONIST,0.0,2.0
58,"3,5-dhpg-(s)",58,GLUTAMATE RECEPTOR AGONIST,1.0,3.0
21,17-pa,58,GLUCOCORTICOID RECEPTOR AGONIST,2.0,4.0
5474,tc-s-7006,58,MAP KINASE INHIBITOR,0.0,5.0
4015,nvp-tnks656,58,TANKYRASE INHIBITOR,3.0,16.0
1106,bw-b70c,58,LIPOXYGENASE INHIBITOR,8.0,21.0
6139,ziritaxestat,58,AUTOTAXIN INHIBITOR,15.0,30.0
3178,ldn193189,59,BONE MORPHOGENIC PROTEIN INHIBITOR,825.0,850.0
4598,prlx-93936,59,VOLTAGE-DEPENDENT ANION SELECTIVE CHANNEL PROTEIN INHIBITOR,635.0,679.0
628,atuveciclib,59,CDK9 INHIBITOR,830.0,859.0
5451,tc-a-2317,60,AURORA KINASE INHIBITOR,349.0,493.0
4768,repotrectinib,60,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,542.0,646.0
2750,hth-01-015,60,PROTEIN KINASE INHIBITOR,13.0,28.0
3743,mrx-2843,60,MER TYROSINE KINASE INHIBITOR,212.0,311.0
4901,rp-001,60,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,6.0,12.0
4784,reversine,60,AURORA KINASE INHIBITOR,264.0,421.0
4719,r112,60,SYK INHIBITOR,16.0,33.0
1990,edasalonexent,60,NFKB PATHWAY INHIBITOR,0.0,2.0
4342,pf-06459988,60,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,57.0,128.0
1107,bx-795,60,IKK INHIBITOR,152.0,293.0
5394,tak-659,60,SPLEEN ASSOCIATED TYROSINE KINASE INHIBITOR,51.0,118.0
5103,selonsertib,60,MAP KINASE ACTIVATOR,76.0,184.0
1295,cfi-400945,60,SERINE/THREONINE KINASE INHIBITOR,136.0,250.0
2614,gsk2239633a,61,CC CHEMOKINE RECEPTOR ANTAGONIST,2.0,6.0
3372,ly311727,61,PHOSPHOLIPASE INHIBITOR,2.0,3.0
3932,nn-dnj,61,GLUCOSIDASE INHIBITOR,2.0,10.0
2747,hpph,61,PHOTOSENSITIZING AGENT,3.0,7.0
1566,cpi-1205,61,EZH2 INHIBITOR,4.0,11.0
5943,vericiguat,61,GUANYLATE CYCLASE STIMULANT,0.0,4.0
3019,jnj-39758979,61,HISTAMINE RECEPTOR ANTAGONIST,1.0,6.0
1715,dcp-la,61,PROTEIN KINASE ACTIVATOR,2.0,5.0
3045,k-ras(g12c)-inhibitor-12,62,K-RAS INHIBITOR,60.0,123.0
4885,rosamicin,62,PROTEIN SYNTHESIS INHIBITOR,5.0,19.0
877,bexagliflozin,62,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,0.0,5.0
3305,lp-533401,63,TRYPTOPHAN HYDROXYLASE INHIBITOR,4.0,6.0
4411,phenylmethylsulfonyl-fluoride,63,SERINE PROTEASE INHIBITOR,0.0,2.0
4327,pf-04885614,63,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,3.0,9.0
6155,zoledronic-acid,63,BONE RESORPTION INHIBITOR,5.0,11.0
5138,sib-1893,64,GLUTAMATE RECEPTOR ANTAGONIST,4.0,7.0
1750,demeclocycline,64,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,2.0,4.0
2293,fezolinetant,64,NEUROKININ RECEPTOR ANTAGONIST,3.0,6.0
2619,gsk239512,64,HISTAMINE RECEPTOR ANTAGONIST,1.0,3.0
422,amifostine,64,REDUCING AGENT,0.0,4.0
3624,mj-15,64,CANNABINOID RECEPTOR ANTAGONIST,1.0,4.0
4979,sancycline,64,ANTITUMOR AGENT,0.0,2.0
138,a-381393,65,DOPAMINE RECEPTOR ANTAGONIST,3.0,4.0
2978,isrib,65,"EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR, PERK INHIBITOR",1.0,2.0
2334,florifenine,65,ANTI-INFLAMMATORY AGENT,1.0,6.0
4829,rislenemdaz,65,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,1.0,2.0
2982,it1t,65,CC CHEMOKINE RECEPTOR ANTAGONIST,5.0,10.0
3004,jhw-007,65,DOPAMINE REUPTAKE INHIBITOR,1.0,7.0
3055,kartogenin,65,CHONDROCYTE DIFFERENTIATION STIMULATOR,5.0,8.0
254,adelmidrol,66,ANTI-INFLAMMATORY AGENT,0.0,2.0
1793,dextrorotation-nimorazole-phosphate-ester,66,ANTIINFECTIVE DRUG,2.0,4.0
326,alinidine,66,BRADYCARDIC EFFECT,1.0,3.0
5739,treprostinil,66,PROSTANOID RECEPTOR AGONIST,2.0,8.0
4120,osilodrostat,66,CYTOCHROME P450 INHIBITOR,2.0,5.0
2535,glecaprevir,67,SERINE PROTEASE INHIBITOR,1.0,5.0
5946,verubecestat,67,BETA SECRETASE INHIBITOR,1.0,2.0
6167,zset1446,67,NICOTINIC RECEPTOR AGONIST,1.0,2.0
576,asapiprant,67,PROSTAGLANDIN INHIBITOR,1.0,3.0
5589,theaflavin,67,ANTIVIRAL,8.0,37.0
651,avoralstat,67,KALLIKREIN INHIBITOR,3.0,6.0
3054,karenitecin,68,TOPOISOMERASE INHIBITOR,2.0,10.0
3813,nastorazepide,68,CCK RECEPTOR ANTAGONIST,1.0,2.0
2715,hemin,68,ENZYME INDUCER,3.0,9.0
3377,ly334370,68,SEROTONIN RECEPTOR AGONIST,1.0,2.0
5293,strontium-ranelate,68,"BONE FORMATION STIMULANT, BONE RESORPTION INHIBITOR",1.0,3.0
3812,nastorazepide,68,CCK RECEPTOR ANTAGONIST,1.0,2.0
977,bms-986020,68,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,0.0,3.0
1075,buserelin,68,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,2.0,7.0
978,bms-986020,68,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,0.0,3.0
979,bms-986020,68,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,0.0,3.0
2713,heclin,69,UBIQUITIN LIGASE INHIBITOR,0.0,5.0
1657,d609,69,PHOSPHOLIPASE INHIBITOR,3.0,4.0
5912,vapendavir,69,ANTIVIRAL,1.0,10.0
2222,evocalcet,69,CALCIUM SENSITIZER,1.0,7.0
4208,paopa,69,DOPAMINE RECEPTOR MODULATOR,6.0,10.0
5941,verdinexor,70,EXPORTIN ANTAGONIST,883.0,887.0
5890,urolithin-a,70,ANTIOXIDANT,1.0,4.0
938,blu9931,70,FGFR INHIBITOR,62.0,149.0
2030,eltanexor,70,EXPORTIN INHIBITOR,767.0,831.0
1642,cysteamine,71,TISSUE TRANSGLUTAMINASE INHIBITOR,5.0,8.0
2518,ggstop,71,GAMMA GLUTAMYLTRANSFERASE INHIBITOR,1.0,3.0
793,baz2-icr,71,BROMODOMAIN INHIBITOR,0.0,6.0
418,ami-1,71,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,4.0,10.0
3656,ml10302,71,SEROTONIN RECEPTOR PARTIAL AGONIST,5.0,8.0
5353,sun-11602,71,FIBROBLAST GROWTH FACTOR MIMETIC,0.0,5.0
3284,loracarbef,71,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,18.0,35.0
5061,sch-202676,71,G PROTEIN-COUPLED RECEPTOR MODULATOR,8.0,29.0
771,batefenterol,72,"ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR AGONIST",7.0,11.0
6064,xd-14,72,BROMODOMAIN INHIBITOR,1.0,3.0
4371,pfi-4,72,BROMODOMAIN INHIBITOR,2.0,5.0
4246,pd-118057,72,POTASSIUM CHANNEL ACTIVATOR,1.0,4.0
4922,ru-ski-43,72,HEDGEHOG PATHWAY INHIBITOR,3.0,6.0
4481,pipotiazine,73,DOPAMINE RECEPTOR ANTAGONIST,1.0,2.0
4312,pf-02413873,73,PROGESTERONE RECEPTOR ANTAGONIST,2.0,6.0
2746,hpgds-in-1,73,PROSTAGLANDIN INHIBITOR,3.0,3.0
394,amenamevir,73,HELICASE PRIMASE INHIBITOR,4.0,7.0
4088,op-0595,73,BETA LACTAMASE INHIBITOR,0.0,2.0
147,a-784168,74,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,1.0,5.0
3164,lasmiditan,74,SEROTONIN RECEPTOR AGONIST,1.0,5.0
3689,mmv-390048,74,PI4K INHIBITOR,2.0,11.0
4594,prinomastat,74,MATRIX METALLOPROTEASE INHIBITOR,1.0,3.0
4200,pamiparib,75,PARP INHIBITOR,36.0,77.0
2716,hepsulfam,75,DNA CROSS-LINKING,5.0,29.0
5168,sjg-136,75,DNA INTERCALATING AGENT,30.0,71.0
2551,glycerol-phenylbutyrate,76,SIGMA RECEPTOR LIGAND,4.0,11.0
2456,galidesivir,76,ANTIVIRAL,2.0,8.0
3393,m8-b,76,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,2.0,8.0
3009,jnj-10397049,76,OREXIN RECEPTOR ANTAGONIST,5.0,10.0
783,bay-60-6583,76,ADENOSINE RECEPTOR AGONIST,6.0,12.0
5122,setmelanotide,76,MELANOCORTIN RECEPTOR AGONIST,5.0,9.0
1448,cj-033466,76,SEROTONIN RECEPTOR AGONIST,5.0,10.0
610,atenolol-(+),76,ADRENERGIC RECEPTOR ANTAGONIST,1.0,7.0
2963,isoflurophate,76,CHOLINESTERASE INHIBITOR,0.0,5.0
4451,pim-447,77,PIM KINASE INHIBITOR,712.0,796.0
5471,tc-s-7003,77,SRC INHIBITOR,831.0,850.0
4951,s-trityl-l-cysteine,77,MITOTIC KINESIN INHIBITOR,282.0,393.0
4253,pd-166285,77,SRC INHIBITOR,836.0,865.0
2042,emd534085,77,KINESIN INHIBITOR,532.0,671.0
4660,ptc-028,77,BMI-1 INHIBITOR,682.0,779.0
2022,eldecalcitol,77,BONE FORMATION STIMULANT,440.0,606.0
4109,ornipressin,77,VASOCONSTRICTOR,596.0,717.0
3376,ly3295668,77,AURORA KINASE INHIBITOR,333.0,498.0
1232,cefazolin,78,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,1.0,3.0
2103,epristeride,78,5 ALPHA REDUCTASE INHIBITOR,4.0,7.0
3357,ly2795050,79,OPIOID RECEPTOR ANTAGONIST,2.0,7.0
186,abx-1431,79,MONOACYLGLYCEROL LIPASE INHIBITOR,2.0,5.0
3232,licostinel,79,NMDA RECEPTOR ANTAGONIST,1.0,5.0
3051,kaf-156,79,ANTIMALARIAL AGENT,8.0,13.0
52,20-hete,79,ION CHANNEL ANTAGONIST,0.0,4.0
3746,msdc-0602k,79,MITOCHONDRIAL PYRUVATE CARRIER MODULATOR,0.0,3.0
5792,tropifexor,79,FXR AGONIST,3.0,7.0
646,avitinib,80,EGFR INHIBITOR,806.0,845.0
4600,prn1371,80,PROTEIN TYROSINE KINASE INHIBITOR,64.0,133.0
2559,gnf-7,80,"GLUCOKINASE INHIBITOR, PROTEIN KINASE INHIBITOR",630.0,735.0
2414,frax486,80,SERINE/THREONINE KINASE INHIBITOR,596.0,706.0
667,az7550,80,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,822.0,856.0
5204,sodium-nitroprusside,81,NITRIC OXIDE DONOR,3.0,10.0
954,bms-566419,81,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,69.0,177.0
1651,d-157495,81,DECAPPING SCAVENGER ENZYME INHIBITOR,24.0,72.0
781,bay-2402234,81,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,127.0,253.0
2419,ft011,82,TGF BETA RECEPTOR INHIBITOR,1.0,4.0
4794,rgx-104,82,LXR AGONIST,1.0,2.0
2052,emricasan,82,CASPASE INHIBITOR,5.0,5.0
4782,revefenacin,82,CHOLINERGIC RECEPTOR ANTAGONIST,0.0,4.0
3844,nemazoline,82,"ADRENERGIC RECEPTOR AGONIST, ADRENERGIC RECEPTOR ANTAGONIST",1.0,3.0
5375,t-807,82,PET RADIOTRACER,5.0,12.0
4711,r-121919,82,CRF RECEPTOR ANTAGONIST,2.0,3.0
2136,esaxerenone,82,MINERALOCORTICOID RECEPTOR ANTAGONIST,0.0,5.0
1880,dipyrocetyl,82,CHELATING AGENT,2.0,7.0
1905,docusate,83,LAXATIVE,0.0,3.0
4902,rq-00203078,83,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,2.0,4.0
609,atb-346,83,CYCLOOXYGENASE INHIBITOR,3.0,6.0
6095,ym-298198,83,GLUTAMATE RECEPTOR ANTAGONIST,2.0,8.0
3739,mrs-1334,83,ADENOSINE RECEPTOR ANTAGONIST,0.0,4.0
1426,cinpa-1,83,CAR ANTAGONIST,2.0,3.0
4735,ralinepag,83,IP1 PROSTACYCLIN RECEPTOR AGONIST,1.0,9.0
1540,cot-inhibitor-1,83,MAPK-INTERACTING KINASE INHIBITOR,2.0,7.0
2536,glesatinib,84,TYROSINE KINASE INHIBITOR,35.0,73.0
1717,ddr1-in-1,84,DISCOIDIN DOMAIN RECEPTOR INHIBITOR,7.0,24.0
5000,savolitinib,84,C-MET INHIBITOR,12.0,18.0
1760,derazantinib,84,TYROSINE KINASE INHIBITOR,32.0,52.0
5165,sitravatinib,84,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,35.0,78.0
3018,jnj-38877618,84,C-MET INHIBITOR,14.0,20.0
4957,s49076,84,TYROSINE KINASE INHIBITOR,9.0,12.0
3905,ningetinib-tosylate,84,PROTEIN TYROSINE KINASE INHIBITOR,23.0,33.0
1370,chlortetracycline,85,PROTEIN SYNTHESIS INHIBITOR,0.0,2.0
1998,ef5,85,CYTOCHROME P450 ACTIVATOR,0.0,5.0
5126,sf-11,85,NEUROPEPTIDE RECEPTOR ANTAGONIST,2.0,4.0
881,bgp-15,85,PARP INHIBITOR,1.0,4.0
642,ave-0991,85,ANGIOTENSIN RECEPTOR AGONIST,1.0,5.0
675,azaserine,85,PURINE ANTAGONIST,2.0,4.0
1369,chlortetracycline,85,PROTEIN SYNTHESIS INHIBITOR,0.0,2.0
241,acumapimod,86,P38 MAPK INHIBITOR,2.0,5.0
1846,dilmapimod,86,P38 MAPK INHIBITOR,2.0,4.0
5344,sulopenem,86,ANTIBACTERIAL,1.0,2.0
1045,bt-11,86,CAMP STIMULANT,0.0,8.0
2990,itx5061,86,SR-BI INHIBITOR,0.0,4.0
4714,r-1487,86,P38 MAPK INHIBITOR,3.0,9.0
6090,yl0919,86,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),3.0,8.0
955,bms-582949,86,P38 MAPK INHIBITOR,5.0,16.0
959,bms-626531,86,P38 MAPK INHIBITOR,2.0,2.0
4860,ro-5028442,87,VASOPRESSIN RECEPTOR ANTAGONIST,2.0,4.0
2765,hydroxocobalamin,87,VITAMIN B,1.0,2.0
4828,risedronate,87,OSTEOCLAST INHIBITOR,3.0,10.0
2236,exo-iwr-1,87,WNT SIGNALING INHIBITOR NEGATIVE CONTROL,4.0,13.0
5459,tc-g-1005,87,G PROTEIN-COUPLED RECEPTOR AGONIST,0.0,4.0
5223,sonepiprazole,88,DOPAMINE RECEPTOR ANTAGONIST,0.0,4.0
3126,l-760735,88,TACHYKININ ANTAGONIST,1.0,5.0
274,afamelanotide,88,MELANOCYTE-STIMULATING HORMONE MIMETIC,5.0,8.0
5527,tenapanor,88,SODIUM/HYDROGEN EXCHANGER INHIBITOR,2.0,6.0
3621,miw-815,88,INTERFERON INDUCER,0.0,2.0
3027,jnj-678,88,RSV FUSION INHIBITOR,1.0,6.0
3758,n-(p-amylcinnamoyl)-anthranilic-acid,88,PHOSPHOLIPASE INHIBITOR,2.0,4.0
5051,sbi-115,89,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,176.0,355.0
5060,scabertopin,89,ANTICANCER AGENT,152.0,307.0
2690,h-151,90,STING ANTAGONIST,4.0,11.0
3136,l-kynurenine,90,ARYL HYDROCARBON RECEPTOR AGONIST,1.0,5.0
4897,rovazolac,90,LXR AGONIST,3.0,23.0
3612,mitapivat,90,PYRUVATE KINASE ISOZYME ACTIVATOR,2.0,6.0
1596,cu-t12-9,90,TOLL-LIKE RECEPTOR AGONIST,3.0,18.0
5428,tapinarof,90,ARYL HYDROCARBON RECEPTOR AGONIST,7.0,21.0
1429,cipargamin,90,ANTIMALARIAL AGENT,10.0,39.0
1394,cid-2745687,91,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,1.0,6.0
1416,cinchonine,91,P GLYCOPROTEIN INHIBITOR,2.0,5.0
1751,denopamine,91,ADRENERGIC RECEPTOR AGONIST,2.0,19.0
236,act-132577,91,ENDOTHELIN RECEPTOR ANTAGONIST,7.0,18.0
1263,ceftizoxim,91,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,1.0,3.0
5457,tc-g-1000,91,ADRENERGIC RECEPTOR AGONIST,0.0,2.0
6035,wh-4-023,91,SRC INHIBITOR,2.0,14.0
1712,dc-260126,91,FREE FATTY ACID RECEPTOR ANTAGONIST,2.0,6.0
4956,s4,91,CARBONIC ANHYDRASE INHIBITOR,0.0,3.0
662,az-7371,92,ANTIBACTERIAL,2.0,11.0
5948,verucerfont,92,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,6.0,11.0
5878,upadacitinib,92,JAK INHIBITOR,13.0,28.0
189,ac-261066,92,RETINOID RECEPTOR AGONIST,7.0,15.0
158,a12b4c3,92,POLYNUCLEOTIDE KINASE/PHOSPHATASE INHIBITOR,2.0,8.0
5526,tenalisib,92,PI3K INHIBITOR,3.0,12.0
1641,cyproterone-acetate,93,ANDROGEN RECEPTOR ANTAGONIST,223.0,274.0
4734,raf709,93,RAF INHIBITOR,83.0,137.0
3236,lifirafenib,93,RAF INHIBITOR,60.0,99.0
3332,lxh254,93,RAF INHIBITOR,171.0,286.0
1208,cc-90003,93,MAP KINASE INHIBITOR,218.0,351.0
1220,cct196969,93,RAF INHIBITOR,271.0,394.0
661,az-628,93,RAF INHIBITOR,74.0,131.0
3678,ml786,93,RAF INHIBITOR,114.0,189.0
1640,cyproterone-acetate,93,ANDROGEN RECEPTOR ANTAGONIST,223.0,274.0
659,az-628,93,RAF INHIBITOR,74.0,131.0
660,az-628,93,RAF INHIBITOR,74.0,131.0
1275,centhaquin,94,ANALGESIC AGENT,3.0,5.0
2047,emixustat,94,RETINOID ISOMEROHYDROLASE INHIBITOR,0.0,4.0
4337,pf-06282999,94,MYELOPEROXIDASE INHIBITOR,1.0,3.0
2639,gsk369796,94,POTASSIUM CHANNEL ANTAGONIST,5.0,20.0
3609,mirogabalin-besylate,94,CALCIUM CHANNEL ANTAGONIST,2.0,4.0
1509,cm-4620,94,CALCIUM RELEASE ACTIVATED CHANNEL MODULATOR,2.0,6.0
3654,mk2-in-1,94,MAP KINASE INHIBITOR,3.0,9.0
3705,monepantel,94,MTOR INHIBITOR,2.0,4.0
461,ampyrone,95,CYCLOOXYGENASE INHIBITOR,0.0,2.0
923,bismuth-subsalicylate,95,ANTACID,1.0,5.0
1162,carbarsone,96,ANTIPROTOZOAL AGENT,1.0,3.0
3983,nsc-636819,96,HISTONE DEMETHYLASE INHIBITOR,4.0,8.0
235,acrylate,96,MUCUS PROTECTING AGENT,2.0,5.0
3924,nky-80,96,ADENYLYL CYCLASE INHIBITOR,3.0,4.0
3867,ngd-98-2,96,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,0.0,2.0
2545,glpg1837,96,CFTR CHANNEL POTENTIATOR,2.0,5.0
232,acoziborole,96,ANTITRYPANOSOMAL,0.0,2.0
3542,methyl-aminolevulinate,96,OXIDIZING AGENT,2.0,7.0
3023,jnj-47965567,96,PURINERGIC RECEPTOR ANTAGONIST,1.0,11.0
1030,bromindione,96,ANTICOAGULANT,1.0,3.0
5255,squaric-acid-dibutyl-ester,96,OXIDATIVE STRESS INDUCER,5.0,9.0
4198,pamabrom,96,DIURETIC,21.0,42.0
2436,furvina,97,QUORUM SENSING SIGNALING INHIBITOR,1.0,6.0
6117,zami-633,97,UREASE INHIBITOR,1.0,3.0
2734,hm-30181,97,P GLYCOPROTEIN INHIBITOR,2.0,2.0
587,asivatrep,97,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,1.0,3.0
1273,centanafadine,97,DOPAMINE REUPTAKE INHIBITOR,3.0,4.0
5811,tuftsin,98,MACROPHAGE ACTIVATOR,1.0,9.0
1074,buramate,98,ANTIEPILEPTIC,0.0,4.0
4418,php-501,98,GABA RECEPTOR ANTAGONIST,0.0,3.0
2082,epetraborole,98,LEUCYL-TRNA SYNTHETASE INHIBITOR,3.0,10.0
2880,inarigivir-soproxil,99,ANTIVIRAL,1.0,4.0
5493,td139,99,ANTI-INFLAMMATORY AGENT,0.0,4.0
477,anagliptin,99,DIPEPTIDYL PEPTIDASE INHIBITOR,0.0,3.0
5372,t-1095,100,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,1.0,2.0
3434,mdl-27531,100,GLYCINE RECEPTOR AGONIST,3.0,6.0
1837,dihydrexidine,100,DOPAMINE RECEPTOR AGONIST,3.0,5.0
1421,cinnamaldehyde,100,"ALDOSE REDUCTASE INHIBITOR, TRPV AGONIST",1.0,7.0
163,a77636,100,DOPAMINE RECEPTOR AGONIST,1.0,10.0
1797,dh-97,100,MELATONIN RECEPTOR ANTAGONIST,3.0,6.0
3973,ns-3623,100,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,0.0,4.0
4031,octodrine,100,ANTITUMOR AGENT,5.0,8.0
4426,pi3kd-in-2,101,PI3K INHIBITOR,5.0,13.0
2271,fenebrutinib,101,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,2.0,4.0
4083,ono-4059,101,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,1.0,9.0
3169,lazertinib,101,TYROSINE KINASE INHIBITOR,30.0,66.0
4689,pyrotinib,101,KINASE INHIBITOR,54.0,98.0
6120,zanubrutinib,101,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,14.0,37.0
1450,ck-101,101,EGFR INHIBITOR,55.0,123.0
3184,leniolisib,101,PI3K INHIBITOR,0.0,2.0
4346,pf-06747775,101,EGFR INHIBITOR,45.0,83.0
4082,ono-4059,101,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,1.0,9.0
4599,prn1008,102,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,3.0,6.0
2438,futibatinib,102,FGFR INHIBITOR,9.0,18.0
590,asp-9521,102,ALDO-KETO REDUCTASE INHIBITOR,1.0,4.0
4715,r-268712,102,SERINE/THREONINE KINASE INHIBITOR,1.0,5.0
4874,rogaratinib,102,FGFR INHIBITOR,14.0,44.0
1552,cp-547632,102,KINASE INHIBITOR,35.0,66.0
4252,pd-161570,102,FGFR INHIBITOR,178.0,279.0
4345,pf-06651600,103,JAK INHIBITOR,2.0,6.0
2970,isoquercitrin,103,ANTIOXIDANT,2.0,6.0
643,ave-3085,103,NITRIC OXIDE SYNTHASE STIMULANT,0.0,3.0
4232,pat-1251,103,LYSYL OXIDASE INHIBITOR,1.0,3.0
758,bamaquimast,103,PROTON PUMP INHIBITOR,0.0,3.0
2853,ilaprazole,103,PROTON PUMP INHIBITOR,3.0,9.0
4732,radotinib,104,BCR-ABL KINASE INHIBITOR,4.0,8.0
329,alisporivir,104,CYCLOPHILIN INHIBITOR,3.0,7.0
3901,nim811,104,MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR,6.0,17.0
3326,lusaperidone,104,ADRENERGIC RECEPTOR ANTAGONIST,1.0,6.0
5641,tinoridine,104,ANTI-INFLAMMATORY AGENT,2.0,3.0
5132,sgs-742,105,GABA RECEPTOR ANTAGONIST,0.0,3.0
2114,epz020411,105,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,1.0,6.0
965,bms-770767,105,11-BETA-HSD1 INHIBITOR,1.0,4.0
3407,mangafodipir,105,CONTRAST AGENT,4.0,7.0
1240,cefiderocol,105,ANTIBACTERIAL,0.0,2.0
3972,ns-309,106,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,7.0,13.0
2860,imazodan,106,PHOSPHODIESTERASE INHIBITOR,11.0,23.0
6027,way-255348,106,PROGESTERONE RECEPTOR ANTAGONIST,4.0,4.0
719,azd8797,106,CC CHEMOKINE RECEPTOR ANTAGONIST,13.0,41.0
4135,oxaceprol,106,ANTI-INFLAMMATORY AGENT,1.0,3.0
5150,sincalide,106,CHOLECYSTOKININ AGONIST,0.0,3.0
1992,edo-s101,107,HDAC INHIBITOR,60.0,133.0
6087,yc-1,107,GUANYLYL CYCLASE ACTIVATOR,128.0,157.0
5608,thk5351,107,PET RADIOTRACER,2.0,7.0
5931,velpatasvir,108,ANTIVIRAL,2.0,5.0
4977,sam-315,108,SEROTONIN RECEPTOR ANTAGONIST,0.0,2.0
4353,pf-4191834,108,LIPOXYGENASE INHIBITOR,6.0,12.0
2036,emamectin,108,GABA RECEPTOR AGONIST,2.0,11.0
2007,efonidipine,109,CALCIUM CHANNEL BLOCKER,1.0,4.0
2422,fucoxanthin,109,ANTICANCER AGENT,1.0,2.0
4331,pf-05175157,109,ACETYL-COA CARBOXYLASE INHIBITOR,3.0,10.0
2494,gefapixant,109,PURINERGIC RECEPTOR ANTAGONIST,2.0,3.0
4516,plx51107,110,BROMODOMAIN INHIBITOR,109.0,203.0
3619,mivebresib,110,BROMODOMAIN INHIBITOR,512.0,616.0
981,bms-986158,110,BROMODOMAIN INHIBITOR,297.0,433.0
2885,incb-057643,110,BROMODOMAIN INHIBITOR,211.0,329.0
702,azd5153,110,BROMODOMAIN INHIBITOR,254.0,402.0
565,arv-825,110,BROMODOMAIN INHIBITOR,407.0,545.0
5534,tenofovir-alafenamide,110,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,22.0,54.0
2918,inx-08189,110,ANTIVIRAL,68.0,119.0
171,abbv-744,110,BROMODOMAIN INHIBITOR,194.0,315.0
5525,ten-010,110,BROMODOMAIN INHIBITOR,218.0,362.0
1622,cyclopamine,111,HEDGEHOG PATHWAY INHIBITOR,4.0,9.0
5259,sr-2211,111,RETINOID RECEPTOR INVERSE AGONIST,4.0,7.0
4340,pf-06412562,111,DOPAMINE RECEPTOR PARTIAL AGONIST,2.0,7.0
2542,glpg0187,111,INTEGRIN ANTAGONIST,1.0,11.0
4588,pridopidine,111,DOPAMINE RECEPTOR ANTAGONIST,2.0,5.0
116,6-diazo-5-oxo-l-norleucine,111,"GLUTAMATE RECEPTOR ANTAGONIST, GLUTAMINASE INHIBITOR",3.0,8.0
652,ax-024,111,CYTOKINE PRODUCTION INHIBITOR,1.0,2.0
1117,ca-4948,112,KINASE INHIBITOR,3.0,6.0
4963,sacubitrilat,112,NEPRILYSIN INHIBITOR,2.0,6.0
2016,elacestrant,112,ESTROGEN RECEPTOR DEGRADER,691.0,749.0
581,ascomycin,112,CALCINEURIN INHIBITOR,3.0,5.0
3385,lylamine,112,CANNABINOID RECEPTOR AGONIST,48.0,78.0
1139,camobucol,112,ANTI-INFLAMMATORY AGENT,0.0,2.0
631,aut-1,112,POTASSIUM CHANNEL ACTIVATOR,4.0,11.0
4978,sameridine,113,OPIOID RECEPTOR MODULATOR,1.0,5.0
5693,tomeglovir,113,ANTIVIRAL,1.0,5.0
1428,cipamfylline,113,PHOSPHODIESTERASE INHIBITOR,2.0,5.0
1132,calcitonin,113,CALCITONIN AGONIST,3.0,10.0
5898,val-tyr,113,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,2.0,4.0
1744,delcasertib,113,PKC INHIBITOR,2.0,3.0
3745,msdc-0160,113,INSULIN SENSITIZER,5.0,15.0
1916,doravirine,113,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,2.0,5.0
4318,pf-03882845,114,MINERALOCORTICOID RECEPTOR ANTAGONIST,1.0,3.0
5481,tcs-2002,114,GLYCOGEN SYNTHASE KINASE INHIBITOR,0.0,5.0
4171,ozenoxacin,114,ANTIINFECTIVE DRUG,1.0,5.0
4319,pf-03882845,114,MINERALOCORTICOID RECEPTOR ANTAGONIST,1.0,3.0
5167,sj-733,114,ATPASE INHIBITOR,1.0,4.0
4041,oglufanide,114,VEGF ANTAGONIST,0.0,3.0
2875,imisopasem-manganese,114,SUPEROXIDE DISMUTASE MIMETIC,0.0,5.0
2677,gw-542573x,114,CALCIUM CHANNEL ACTIVATOR,2.0,5.0
5443,tauroglycocholate,114,MEMBRANE PERMEABILITY ENHANCER,1.0,4.0
3860,neuropathiazol,114,NEURAL STEM CELL INDUCER,0.0,3.0
2316,fisetin,115,AURORA KINASE INHIBITOR,2.0,8.0
3642,mk-5046,115,BOMBESIN RECEPTOR AGONIST,0.0,4.0
2633,gsk2981278,115,ROR MODULATOR,5.0,11.0
2489,gdc-0927,115,ESTROGEN RECEPTOR ANTAGONIST,2.0,6.0
2892,indeglitazar,115,PPAR RECEPTOR AGONIST,4.0,12.0
2878,impentamine,115,HISTAMINE RECEPTOR ANTAGONIST,1.0,3.0
4947,s-38093,115,HISTAMINE RECEPTOR ANTAGONIST,0.0,4.0
4480,pipofezine,115,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),1.0,5.0
5489,tcs-ox2-29,116,OREXIN RECEPTOR ANTAGONIST,1.0,5.0
3617,mitotane,116,ANTINEOPLASTIC AGENT,2.0,3.0
3584,micafungin,116,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",1.0,2.0
6096,ym-298198-desmethyl,116,GLUTAMATE RECEPTOR ANTAGONIST,5.0,8.0
6094,ym-244769,116,SODIUM/CALCIUM EXCHANGE INHIBITOR,0.0,3.0
3152,lanabecestat,117,BETA SECRETASE INHIBITOR,1.0,2.0
2541,gln-1062,117,CHOLINESTERASE INHIBITOR,0.0,4.0
5612,thymalfasin,117,IMMUNE RESPONSE MODULATOR,0.0,2.0
5897,vadadustat,117,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,0.0,4.0
3820,nb-001,117,ANTIVIRAL,0.0,2.0
1762,desidustat,117,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,2.0,7.0
694,azd3839,117,BETA-SECRETASE INHIBITOR,0.0,2.0
5695,tomivosertib,117,MAPK-INTERACTING KINASE INHIBITOR,2.0,3.0
4691,pz-2891,118,PANTOTHENATE KINASE ACTIVATOR,2.0,4.0
1725,decloxizine,118,HISTAMINE RECEPTOR ANTAGONIST,0.0,3.0
4869,roblitinib,118,FGFR INHIBITOR,0.0,2.0
2527,ginsenoside-re,118,ANTI-INFLAMMATORY AGENT,1.0,7.0
1184,caroverin,118,CYTOCHROME P450 INHIBITOR,2.0,6.0
353,alpha-methylserotonin,118,SEROTONIN RECEPTOR AGONIST,0.0,6.0
4728,rad140,118,ANDROGEN RECEPTOR MODULATOR,2.0,3.0
3118,l-694247,118,SEROTONIN RECEPTOR AGONIST,0.0,4.0
1778,devazepide,119,CCK RECEPTOR ANTAGONIST,1.0,6.0
2694,ha-130,119,AUTOTAXIN INHIBITOR,3.0,13.0
2606,gsk189254,119,HISTAMINE RECEPTOR ANTAGONIST,3.0,8.0
2795,ibotenic-acid,119,GLUTAMATE RECEPTOR AGONIST,1.0,6.0
1329,chc,119,MONOCARBOXYLATE TRANSPORTER INHIBITOR,5.0,11.0
4996,saroglitazar,119,PPAR RECEPTOR AGONIST,4.0,13.0
1027,bromebric-acid,119,"DNA SYNTHESIS INHIBITOR, PURINE ANTAGONIST",3.0,5.0
4370,pfi-3,119,BROMODOMAIN INHIBITOR,1.0,5.0
4039,ogerin,119,G PROTEIN-COUPLED RECEPTOR MODULATOR,2.0,7.0
2622,gsk2606414,120,PROTEIN KINASE INHIBITOR,8.0,23.0
3005,ji-101,120,KINASE INHIBITOR,8.0,13.0
2636,gsk3179106,120,RET TYROSINE KINASE INHIBITOR,13.0,25.0
639,avapritinib,120,KIT INHIBITOR,16.0,33.0
472,amz30,120,PROTEIN PHOSPHATASE INHIBITOR,2.0,8.0
4517,plx647,120,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,6.0,14.0
5336,sulfatinib,120,TYROSINE KINASE INHIBITOR,27.0,57.0
5297,su16f,120,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,5.0,8.0
195,ac260584,121,CHOLINERGIC RECEPTOR AGONIST,0.0,2.0
5631,tigecycline,121,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,1.0,2.0
5720,tram-39,121,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,2.0,10.0
5935,ver-155008,121,HSP INHIBITOR,11.0,37.0
4952,s15535,121,SEROTONIN RECEPTOR AGONIST,1.0,4.0
3082,km-0118,121,ANTICANCER AGENT,1.0,4.0
5036,sb-612111,121,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,13.0,36.0
5927,veledimex,121,CYTOCHROME P450 INHIBITOR,3.0,6.0
3196,letrazuril,122,ANTIINFECTIVE DRUG,3.0,3.0
1595,cu-cpt-4a,122,TOLL-LIKE RECEPTOR INHIBITOR,1.0,4.0
2502,gemigliptin,122,DIPEPTIDYL PEPTIDASE INHIBITOR,0.0,3.0
1993,edonerpic-maleate,122,BETA AMYLOID INHIBITOR,1.0,5.0
3203,levamlodipine,122,CALCIUM CHANNEL BLOCKER,11.0,25.0
3309,lsz-102,122,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),0.0,3.0
2219,evenamide,123,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,1.0,5.0
5156,siremadlin,123,MDM INHIBITOR,2.0,6.0
2945,irgd-peptide,123,INTEGRIN SIGNALING ACTIVATOR,1.0,8.0
3580,mi-14,124,PI4K INHIBITOR,7.0,19.0
4237,pbt-1033,124,CHELATING AGENT,53.0,137.0
4183,paeoniflorin,124,ANTICONVULSANT,0.0,7.0
294,ai-10-49,124,CORE BINDING FACTOR INHIBITOR,153.0,335.0
3673,ml324,124,HISTONE LYSINE DEMETHYLASE INHIBITOR,7.0,19.0
5275,ssr180711,125,ACETYLCHOLINE RECEPTOR AGONIST,3.0,7.0
6145,zln024,125,AMPK ACTIVATOR,5.0,12.0
1550,cp-471474,125,MATRIX METALLOPROTEASE INHIBITOR,4.0,11.0
5877,undecylenic-acid,125,OTHER ANTIFUNGAL,1.0,4.0
5613,thymopentin,126,IMMUNE RESPONSE STIMULATOR,1.0,4.0
4236,pbi-4050,126,FREE FATTY ACID RECEPTOR AGONIST,1.0,2.0
3965,nps-2407,126,GLUTAMATE RECEPTOR ANTAGONIST,4.0,7.0
1449,cj-13610,127,LIPOXYGENASE INHIBITOR,1.0,2.0
3707,monocrotaline,127,ANTITUMOR AGENT,0.0,2.0
2048,emodepside,127,NEMATOCIDE,1.0,4.0
231,acolbifene,127,ESTROGEN RECEPTOR ANTAGONIST,3.0,5.0
2462,gamithromycin,128,ANTIBACTERIAL,0.0,3.0
5416,taminadenant,128,ADENOSINE RECEPTOR ANTAGONIST,0.0,3.0
1289,ceruletide,128,CCK RECEPTOR AGONIST,4.0,7.0
528,apronal,128,CYTOCHROME P450 MODULATOR,1.0,3.0
898,bictegravir,128,HIV INTEGRASE INHIBITOR,2.0,3.0
3641,mk-4074,128,ACETYL-COA CARBOXYLASE INHIBITOR,2.0,2.0
1192,casin,128,GTPASE INHIBITOR,8.0,15.0
1881,diquafosol,128,PURINERGIC RECEPTOR ACTIVATOR,2.0,4.0
3238,ligustilide,129,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,1.0,3.0
3638,mk-2894,129,PROSTAGLANDIN INHIBITOR,0.0,3.0
2560,gnti,130,OPIOID RECEPTOR ANTAGONIST,2.0,5.0
974,bms-911543,130,JAK INHIBITOR,6.0,26.0
5226,soraprazan,130,PROTON PUMP INHIBITOR,3.0,6.0
5076,sd-0006,130,P38 MAPK INHIBITOR,2.0,8.0
2615,gsk2256098,131,KINASE INHIBITOR,1.0,4.0
1796,dg051,131,LEUKOTRIENE SYNTHESIS INHIBITOR,0.0,3.0
4533,polymyxin-b-sulfate,131,BACTERIAL PERMEABILITY INDUCER,2.0,5.0
3670,ml298,131,PHOSPHOLIPASE INHIBITOR,3.0,11.0
5923,vecabrutinib,131,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,4.0,9.0
5057,sc-51089,131,PROSTANOID RECEPTOR ANTAGONIST,3.0,6.0
6137,zinc-undecylenate,131,OTHER ANTIFUNGAL,7.0,14.0
4456,pimodivir,131,ANTIVIRAL,1.0,3.0
4760,relugolix,132,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,1.0,2.0
4778,retagliptin,132,DIPEPTIDYL PEPTIDASE INHIBITOR,1.0,2.0
4336,pf-06273340,132,TYROSINE KINASE RECEPTOR INHIBITOR,2.0,2.0
4215,parcetasal,132,ANTI-INFLAMMATORY AGENT,1.0,5.0
778,bay-1251152,133,CDK9 INHIBITOR,882.0,886.0
1670,dalbavancin,133,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,880.0,884.0
2379,fn-1501,133,TYROSINE KINASE INHIBITOR,861.0,873.0
1614,cyc065,133,CDK INHIBITOR,881.0,885.0
5846,ubp-296,133,GLUTAMATE RECEPTOR ANTAGONIST,884.0,886.0
4130,ots514,133,TOPK INHIBITOR,887.0,890.0
5716,trabectedin,133,ANTITUMOR AGENT,888.0,890.0
946,bms-214662,133,FARNESYLTRANSFERASE INHIBITOR,882.0,888.0
3361,ly2857785,133,CDK INHIBITOR,890.0,891.0
1424,cinobufotalin,133,ANTICANCER AGENT,874.0,878.0
3325,lurbinectedin,133,DNA BINDING AGENT,878.0,889.0
699,azd4573,133,CDK9 INHIBITOR,887.0,887.0
5648,tipelukast,134,LEUKOTRIENE RECEPTOR ANTAGONIST,2.0,6.0
1898,dmps,134,CHELATING AGENT,1.0,3.0
1580,crisdesalazine,134,FREE RADICAL SCAVENGER,1.0,3.0
5220,solriamfetol,134,DOPAMINE REUPTAKE INHIBITOR,1.0,5.0
5151,sinefungin,135,"DNA METHYLTRANSFERASE INHIBITOR, RNA SYNTHESIS INHIBITOR",3.0,6.0
6008,vu591,135,POTASSIUM CHANNEL BLOCKER,2.0,3.0
4522,pnu-177864,135,DOPAMINE RECEPTOR ANTAGONIST,2.0,7.0
3024,jnj-54175446,136,PURINERGIC RECEPTOR ANTAGONIST,2.0,8.0
5214,sofosbuvir-impurity-m,136,ANTIVIRAL,2.0,7.0
2751,hthq,136,ANTIOXIDANT,3.0,10.0
5306,sugammadex,136,NEUROMUSCULAR BLOCKADE REVERSAL AGENT,1.0,2.0
4857,ro-48-6791,136,GABA RECEPTOR MODULATOR,2.0,3.0
4498,pirozadil,136,HYPOLIPIDEMIC,3.0,4.0
4657,psi-697,136,P SELECTIN INHIBITOR,0.0,3.0
875,bevenopran,136,OPIOID RECEPTOR ANTAGONIST,0.0,4.0
1518,coh29,137,RIBONUCLEOTIDE REDUCTASE INHIBITOR,210.0,336.0
395,ametantrone,137,ANTICANCER AGENT,544.0,691.0
2221,evobrutinib,137,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,1.0,4.0
5970,visomitin,137,ANTIOXIDANT,835.0,869.0
345,alovudine,137,DNA SYNTHESIS MARKER,13.0,43.0
3616,mitoquinone,137,ANTIOXIDANT,722.0,790.0
3090,kpt-9274,137,NAMPT INHIBITOR,390.0,522.0
2453,gal-021,137,CALCIUM CHANNEL BLOCKER,2.0,15.0
5768,trilaciclib,138,CDK INHIBITOR,72.0,192.0
2337,flt3-in-1,138,FLT3 INHIBITOR,360.0,541.0
5889,urmc-099,138,MIXED LINEAGE KINASE INHIBITOR,77.0,174.0
4078,on123300,138,CDK INHIBITOR,65.0,147.0
4685,pyrintegrin,138,INTEGRIN SIGNALING ACTIVATOR,114.0,219.0
532,apy0201,138,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,182.0,263.0
3859,neurodazine,139,NEUROGENESIS OF NON-PLURIPOTENT C2C12 MYOBLAST INDUCER,3.0,8.0
4764,remodelin,139,TRANSFERASE INHIBITOR,0.0,4.0
6088,yil-781,139,GHRELIN RECEPTOR ANTAGONIST,3.0,7.0
93,"4-phenyl-1,2,3,4-tetrahydroisoquinoline",139,DOPAMINE RELEASE INHIBITOR,3.0,7.0
3971,ns-19504,139,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,1.0,4.0
2826,icrt-14,139,"BETA CATENIN INHIBITOR, WNT SIGNALING INHIBITOR",2.0,12.0
5848,ubp-310,140,GLUTAMATE RECEPTOR ANTAGONIST,2.0,6.0
2013,ei1,140,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,0.0,4.0
4748,rauwolscine,140,ADRENERGIC RECEPTOR ANTAGONIST,6.0,10.0
1022,brl-44408,140,ADRENERGIC RECEPTOR ANTAGONIST,6.0,13.0
3823,nbi-98782,140,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,2.0,4.0
4658,psncbam-1,140,CANNABINOID RECEPTOR MODULATOR,2.0,6.0
516,api-1,141,AKT INHIBITOR,409.0,505.0
531,apy-29,141,SERINE/THREONINE KINASE INHIBITOR,775.0,819.0
251,adavivint,141,WNT PATHWAY INHIBITOR,593.0,680.0
3244,linaprazan,142,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,2.0,3.0
2745,hp-228,142,NITRIC OXIDE SYNTHASE INHIBITOR,1.0,3.0
5241,spautin-1,142,DEUBIQUITINASE INHIBITOR,35.0,89.0
4344,pf-06650833,142,KINASE INHIBITOR,3.0,8.0
624,atractylenolide-i,142,JAK INHIBITOR,1.0,4.0
983,bms-986205,142,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",6.0,19.0
1966,dynasore,143,DYNAMIN INHIBITOR,4.0,14.0
1078,butabindide,143,TRIPEPTIDYL PEPTIDASE INHIBITOR,2.0,5.0
5160,sis3,143,SERINE/THREONINE KINASE INHIBITOR,8.0,28.0
4865,ro-67-7476,143,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,3.0,6.0
6125,zd-0947,144,POTASSIUM CHANNEL ACTIVATOR,1.0,4.0
5037,sb-649868,144,OREXIN RECEPTOR ANTAGONIST,0.0,3.0
715,azd7986,144,DIPEPTIDYL PEPTIDASE INHIBITOR,0.0,6.0
4378,pha-568487,144,NICOTINIC RECEPTOR AGONIST,3.0,6.0
4348,pf-06840003,145,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",0.0,2.0
3001,j147,145,BDNF INDUCER,1.0,5.0
5843,uamc-00039,145,DIPEPTIDYL PEPTIDASE INHIBITOR,0.0,4.0
3327,lusutrombopag,145,THROMBOPOIETIN RECEPTOR AGONIST,1.0,2.0
6156,zoliflodacin,145,ANTIBACTERIAL,1.0,2.0
348,alpha-asarone,145,"CYTOCHROME P450 INHIBITOR, HMGCR INHIBITOR",0.0,4.0
2144,esonarimod,145,ANTIRHEUMATIC DRUG,2.0,2.0
4622,propagermanium,145,"CCR AGONIST, INTERFERON RECEPTOR AGONIST",1.0,5.0
1046,btb06584,146,ATPASE INHIBITOR,0.0,3.0
1391,cicloprofen,146,CYCLOOXYGENASE INHIBITOR,2.0,2.0
3329,luzindole,146,MELATONIN RECEPTOR ANTAGONIST,3.0,8.0
157,a-987306,146,HISTAMINE RECEPTOR ANTAGONIST,2.0,7.0
2667,gw-1100,146,G PROTEIN-COUPLED RECEPTOR AGONIST,4.0,7.0
1252,cefotaxime,146,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,3.0,5.0
5434,tartaric-acid,146,ANTIOXIDANT,0.0,3.0
3204,levcromakalim,146,POTASSIUM CHANNEL ACTIVATOR,2.0,8.0
1161,carbaril,146,ACETYLCHOLINESTERASE INHIBITOR,1.0,4.0
1974,e7046,147,PROSTANOID RECEPTOR ANTAGONIST,3.0,11.0
555,aripiprazole-lauroxil,147,SEROTONIN RECEPTOR AGONIST,3.0,3.0
5561,tetomilast,147,PHOSPHODIESTERASE INHIBITOR,0.0,3.0
2441,g-749,148,TYROSINE KINASE INHIBITOR,583.0,695.0
5299,su9516,148,CDK INHIBITOR,17.0,44.0
761,banoxantrone,148,TOPOISOMERASE INHIBITOR,343.0,520.0
785,bay-61-3606,148,SYK INHIBITOR,11.0,57.0
5776,trimetrexate,148,DIHYDROFOLATE REDUCTASE INHIBITOR,635.0,769.0
5147,simurosertib,148,KINASE INHIBITOR,312.0,473.0
4349,pf-06873600,148,CDK INHIBITOR,249.0,416.0
813,belotecan,149,TOPOISOMERASE INHIBITOR,842.0,864.0
1280,cep-40783,149,AXL KINASE INHIBITOR,490.0,635.0
2879,inarigivir,149,ANTIVIRAL,635.0,736.0
620,atorvastatin,149,HMGCR INHIBITOR,21.0,48.0
621,atorvastatin,149,HMGCR INHIBITOR,21.0,48.0
208,acelarin,149,ANTICANCER AGENT,727.0,798.0
3002,jd-5037,149,CANNABINOID RECEPTOR ANTAGONIST,726.0,796.0
1976,e7820,149,ANGIOGENESIS INHIBITOR,677.0,761.0
2530,gk921,149,TRANSGLUTAMINASE INHIBITOR,831.0,861.0
4501,pitavastatin,149,HMGCR INHIBITOR,270.0,362.0
4500,pitavastatin,149,HMGCR INHIBITOR,270.0,362.0
3799,napamezole,150,"ADRENERGIC RECEPTOR ANTAGONIST, MONOAMINE REUPTAKE INHIBITOR",4.0,6.0
3186,leonurine,150,ANTI-INFLAMMATORY AGENT,0.0,2.0
3719,motapizone,150,PHOSPHODIESTERASE INHIBITOR,2.0,4.0
2209,etrabamine,150,DOPAMINE RECEPTOR AGONIST,1.0,4.0
3546,methylcobalamin,150,VITAMIN B,1.0,3.0
4862,ro-5263397,150,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,1.0,3.0
5258,sr-1664,151,PPAR RECEPTOR LIGAND,1.0,6.0
4954,s1p1-agonist-iii,151,SPHINGOSINE KINASE INHIBITOR,2.0,5.0
4823,riodoxol,151,OTHER ANTIBIOTIC,0.0,5.0
5828,tyrphostin-ag-825,151,PROTEIN TYROSINE KINASE INHIBITOR,3.0,7.0
4791,rg7834,152,ANTIVIRAL,218.0,473.0
2591,gs-967,152,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,0.0,2.0
3544,methylbenactyzium-bromide,152,CHOLINERGIC RECEPTOR ANTAGONIST,3.0,7.0
382,am211,152,PROSTAGLANDIN INHIBITOR,1.0,3.0
816,benactyzine,152,BUTYRYLCHOLINESTERASE INHIBITOR,0.0,3.0
5254,squalamine,153,ANTIVIRAL,2.0,9.0
1458,clanfenur,153,ANTICANCER AGENT,5.0,16.0
683,azd1390,153,ATM KINASE INHIBITOR,6.0,18.0
2426,fumagillin,154,METHIONINE AMINOPEPTIDASE INHIBITOR,19.0,70.0
4995,sardomozide,154,S-ADENOSYLMETHIONINE DECARBOXYLASE INHIBITOR,575.0,726.0
282,ag-556,154,TYROSINE KINASE INHIBITOR,1.0,6.0
223,acetylspiramycin,154,OTHER ANTIBIOTIC,1.0,3.0
755,baloxavir-marboxil,154,ENDONUCLEASE INHIBITOR,0.0,6.0
5424,tannic-acid,154,PARG INHIBITOR,24.0,56.0
6151,zm-39923,154,JAK INHIBITOR,6.0,16.0
1048,btk-in-1,155,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,0.0,2.0
3296,lotamilast,155,PHOSPHODIESTERASE INHIBITOR,1.0,6.0
3224,lgd-6972,155,GLUCAGON RECEPTOR ANTAGONIST,0.0,3.0
2749,ht-2157,155,GALANIN RECEPTOR 3 ANTAGONIST,0.0,8.0
2658,guancydine,155,ANTIHYPERTENSIVE AGENT,1.0,2.0
3552,methylparaben,156,OTHER ANTIFUNGAL,3.0,7.0
3712,morantel,156,ACETYLCHOLINE RECEPTOR AGONIST,2.0,3.0
3207,levobetaxolol,156,ADRENERGIC RECEPTOR ANTAGONIST,2.0,11.0
627,atropine-oxide,156,ACETYLCHOLINE RECEPTOR ANTAGONIST,3.0,15.0
786,bay-8002,157,MONOCARBOXYLATE TRANSPORTER INHIBITOR,14.0,46.0
1113,c188-9,157,STAT INHIBITOR,150.0,265.0
540,ar-c155858,157,MONOCARBOXYLATE TRANSPORTER INHIBITOR,36.0,63.0
1083,butaprost,157,PROSTAGLANDIN RECEPTOR AGONIST,1.0,2.0
3826,ncx-1015,158,INTERLEUKIN SYTHESIS STIMULATOR,7.0,14.0
711,azd7594,158,GLUCOCORTICOID RECEPTOR MODULATOR,12.0,22.0
1764,desisobutyryl-ciclesonide,158,CYTOCHROME P450 INHIBITOR,18.0,41.0
3462,megestrol,158,PROGESTERONE RECEPTOR AGONIST,1.0,4.0
5746,triamcinolone-hexacetonide,158,ANTI-INFLAMMATORY AGENT,3.0,7.0
135,a-1120,159,RETINOID RECEPTOR LIGAND,2.0,6.0
2023,eleclazine,159,LATE SODIUM CURRENT INHIBITOR,2.0,4.0
2712,hc-070,159,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,2.0,6.0
4731,radiprodil,159,ACETYLCHOLINE RECEPTOR ANTAGONIST,0.0,2.0
1264,ceftobiprole,159,ANTIINFECTIVE DRUG,2.0,2.0
5606,thiotepa,159,CYTOCHROME P450 INHIBITOR,2.0,8.0
5403,talaporfin,160,PHOTOSENSITIZING AGENT,0.0,3.0
1668,daidzin,160,ANTIOXIDANT,1.0,2.0
1844,dihydroxyphenylglycine,160,GLUTAMATE RECEPTOR AGONIST,3.0,11.0
4635,propyphenazone,160,ANTI-INFLAMMATORY AGENT,1.0,2.0
4924,ruboxistaurin,161,PKC INHIBITOR,47.0,137.0
3595,milademetan,161,MDM INHIBITOR,199.0,229.0
2869,imidazoacridinone,161,ANTICANCER AGENT,52.0,100.0
2517,gf109203x,161,PKC INHIBITOR,12.0,35.0
2628,gsk2830371,161,PROTEIN PHOSPHATASE INHIBITOR,7.0,17.0
155,a-939572,162,STEAROYL-COA DESATURASE INHIBITOR,28.0,68.0
2142,esomeprazole,162,ATPASE INHIBITOR,1.0,3.0
2366,fluralaner,162,GABA RECEPTOR ANTAGONIST,3.0,9.0
580,asciminib,162,BCR-ABL KINASE INHIBITOR,6.0,25.0
2143,esomeprazole,162,ATPASE INHIBITOR,1.0,3.0
4354,pf-429242,162,SREBP INHIBITOR,47.0,82.0
5113,seratrodast,163,PROSTANOID RECEPTOR ANTAGONIST,0.0,3.0
1427,cintirorgon,163,ROR AGONIST,4.0,6.0
4225,parsaclisib,164,PI3K INHIBITOR,3.0,6.0
4292,peposertib,164,DNA DEPENDENT PROTEIN KINASE INHIBITOR,18.0,72.0
2936,ipi549,164,PI3K INHIBITOR,13.0,36.0
5099,seletalisib,164,PI3K INHIBITOR,4.0,9.0
1196,catharanthine,165,TUBULIN POLYMERIZATION INHIBITOR,3.0,12.0
4662,ptc-209,165,BMI-1 INHIBITOR,4.0,17.0
4661,ptc-209,165,BMI-1 INHIBITOR,4.0,17.0
3518,methacycline,165,PROTEIN SYNTHESIS INHIBITOR,0.0,3.0
3517,methacycline,165,PROTEIN SYNTHESIS INHIBITOR,0.0,3.0
3519,methacycline,165,PROTEIN SYNTHESIS INHIBITOR,0.0,3.0
2315,firsocostat,166,ACETYL-COA CARBOXYLASE INHIBITOR,676.0,755.0
3498,mertansine,166,MICROTUBULE INHIBITOR,739.0,807.0
4076,omtriptolide,166,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,811.0,842.0
2187,ethynylcytidine,166,ANTIMETABOLITE,850.0,863.0
2072,entasobulin,166,TUBULIN POLYMERIZATION INHIBITOR,338.0,500.0
4984,sapacitabine,166,DNA SYNTHESIS INHIBITOR,681.0,790.0
2127,eribulin,166,MICROTUBULE INHIBITOR,743.0,818.0
5719,tradipitant,166,NEUROKININ RECEPTOR ANTAGONIST,700.0,776.0
153,a-887826,167,SODIUM CHANNEL BLOCKER,4.0,16.0
967,bms-779788,167,LXR AGONIST,1.0,8.0
3634,mk-1903,168,NIACIN RECEPTOR AGONIST,1.0,3.0
4056,olodanrigan,168,ANGIOTENSIN ANTAGONIST,2.0,4.0
5476,tc-sp-14,168,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,2.0,4.0
3842,nelociguat,168,GUANYLATE CYCLASE STIMULANT,1.0,5.0
3882,nicodicosapent,168,STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR,2.0,8.0
5305,sufugolix,168,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,0.0,3.0
5925,vedaprofen,169,ANTI-INFLAMMATORY AGENT,1.0,4.0
5982,vorasidenib,169,ISOCITRATE DEHYDROGENASE INHIBITOR,0.0,2.0
2771,hydroxysafflor-yellow-a,169,ANTITUMOR AGENT,1.0,2.0
5937,veralipride,169,DOPAMINE RECEPTOR ANTAGONIST,0.0,3.0
2554,gm-1485,169,IMMUNOPHILIN LIGAND,0.0,2.0
533,apyramide,169,CYCLOOXYGENASE INHIBITOR,2.0,4.0
74,3-methyl-gaba,170,GABA AMINOTRANSFERASE ACTIVATOR,22.0,36.0
3401,madrasin,170,CELL SPLICING INHIBITOR,37.0,71.0
1591,ct7001,170,CDK INHIBITOR,852.0,869.0
503,ap-18,170,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,709.0,796.0
4462,pindolol-(-),171,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",5.0,9.0
332,allicin,171,CYTOKINE PRODUCTION INHIBITOR,1.0,6.0
3828,ndt-9513727,171,COMPLEMENT ANTAGONIST,3.0,6.0
1795,dg-172,171,PPAR RECEPTOR INVERSE AGONIST,15.0,37.0
1962,dwk-1339,171,BETA AMYLOID AGGREGATION INHIBITOR,1.0,7.0
95,4bp-tqs,172,NICOTINIC RECEPTOR AGONIST,5.0,10.0
5464,tc-i-2014,172,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,3.0,5.0
2984,itd-1,172,TGF BETA RECEPTOR INHIBITOR,2.0,10.0
1969,e-2001,172,ANTIOXIDANT,0.0,3.0
5910,vaniprevir,172,SERINE PROTEASE INHIBITOR,0.0,2.0
4676,pyrantel-pamoate,172,NEUROMUSCULAR BLOCKER,1.0,5.0
5203,sodium-nitrite,172,NITRIC OXIDE DONOR,2.0,4.0
4377,pha-543613,172,NICOTINIC RECEPTOR AGONIST,3.0,7.0
3632,mk-1064,172,OREXIN RECEPTOR ANTAGONIST,1.0,3.0
2688,gw274150,173,NITRIC OXIDE SYNTHASE INHIBITOR,2.0,5.0
1272,cenobamate,173,"GABA RECEPTOR MODULATOR, VOLTAGE-GATED SODIUM CHANNEL BLOCKER",0.0,5.0
886,bi-409306,173,PHOSPHODIESTERASE INHIBITOR,1.0,2.0
2709,hbed,173,CHELATING AGENT,2.0,7.0
2,"1,4-butanediol",174,"BENZODIAZEPINE RECEPTOR AGONIST, GAMMA HYDROXYBUTYRIC ACID AGONIST",3.0,9.0
2471,gant-61,174,GLI ANTAGONIST,5.0,13.0
4479,pipobroman,174,DNA ALKYLATING AGENT,2.0,5.0
600,at-1015,174,SEROTONIN RECEPTOR ANTAGONIST,4.0,9.0
5717,trabodenoson,175,ADENOSINE RECEPTOR AGONIST,0.0,2.0
945,bms-207940,175,ENDOTHELIN RECEPTOR ANTAGONIST,1.0,2.0
3969,ns-11394,175,GABA RECEPTOR AGONIST,2.0,6.0
2317,fisogatinib,175,FIBROBLAST GROWTH FACTOR INHIBITOR,3.0,9.0
4347,pf-06751979,175,BETA SECRETASE INHIBITOR,3.0,9.0
3521,methantheline,175,ACETYLCHOLINE RECEPTOR ANTAGONIST,0.0,4.0
1457,clamikalant,175,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,0.0,4.0
2483,gdc-0575,176,CHK INHIBITOR,726.0,767.0
780,bay-1895344,176,ATR KINASE INHIBITOR,822.0,863.0
1221,cct245737,176,KINASE INHIBITOR,340.0,447.0
5972,vl285,177,PROTAC,0.0,2.0
5024,sb-297006,177,CC CHEMOKINE RECEPTOR ANTAGONIST,6.0,14.0
5742,tretinoin,177,"RETINOID RECEPTOR AGONIST, RETINOID RECEPTOR LIGAND",8.0,31.0
202,acebilustat,177,LEUKOTRIENE INHIBITOR,3.0,11.0
1328,ch55,177,RETINOID RECEPTOR BINDER,9.0,23.0
2119,er-50891,178,RETINOID RECEPTOR ANTAGONIST,2.0,2.0
3847,nemorexant,178,OREXIN RECEPTOR ANTAGONIST,1.0,4.0
3344,ly231617,178,LIPID PEROXIDASE INHIBITOR,0.0,5.0
2191,etifoxine,178,GABA RECEPTOR MODULATOR,0.0,3.0
1542,coti-2,179,ANTICANCER AGENT,1.0,4.0
5712,tp-003,179,GABA RECEPTOR INVERSE AGONIST,1.0,4.0
3686,mm-206,180,STAT INHIBITOR,91.0,186.0
6018,walrycin-b,180,TRANSCRIPTIONAL REGULATORY PROTEIN WALR,269.0,383.0
5783,trodusquemine,180,TYROSINE PHOSPHATASE INHIBITOR,42.0,130.0
5819,ty-52156,180,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,21.0,53.0
4335,pf-06260414,180,ANDROGEN RECEPTOR MODULATOR,5.0,12.0
2257,fasoracetam,181,GABA RECEPTOR ANTAGONIST,0.0,2.0
81,4-(aminomethyl)benzoic-acid,181,HEMOSTATIC AGENT,0.0,2.0
1917,dorsomorphin,181,AMPK INHIBITOR,2.0,7.0
5397,tak-779,181,CC CHEMOKINE RECEPTOR ANTAGONIST,0.0,3.0
3665,ml213,182,POTASSIUM CHANNEL ACTIVATOR,2.0,5.0
4240,pci-27483,182,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,0.0,4.0
4339,pf-06409577,183,PROTEIN KINASE ACTIVATOR,0.0,6.0
2261,febuprol,183,CHOLERETIC AGENT,0.0,2.0
2632,gsk2881078,183,ANDROGEN RECEPTOR MODULATOR,0.0,4.0
679,azd0156,183,ATM KINASE INHIBITOR,1.0,2.0
3868,ngp555,183,GAMMA SECRETASE MODULATOR,0.0,3.0
5879,upamostat,184,SERINE PROTEASE INHIBITOR,45.0,131.0
1967,dynole-34-2,184,DYNAMIN INHIBITOR,2.0,8.0
1124,caccinh-a01,184,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,2.0,12.0
1652,d-3263,184,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,21.0,51.0
407,amg-510,184,K-RAS INHIBITOR,5.0,14.0
4811,rilapladib,184,PHOSPHOLIPASE INHIBITOR,22.0,57.0
3422,mavatrep,184,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,21.0,64.0
3083,kme-4,185,PROSTAGLANDIN INHIBITOR,2.0,4.0
586,asimadoline,185,OPIOID RECEPTOR AGONIST,0.0,2.0
4338,pf-06305591,185,SODIUM CHANNEL BLOCKER,2.0,4.0
648,avn-492,185,SEROTONIN RECEPTOR ANTAGONIST,1.0,2.0
1307,cgp-25454a,185,DOPAMINE RECEPTOR ANTAGONIST,0.0,2.0
3409,manitimus,185,DEHYDROGENASE INHIBITOR,0.0,4.0
1673,dalfopristin,185,ANTIBACTERIAL,0.0,5.0
6170,zuranolone,185,GABA RECEPTOR AGONIST,1.0,2.0
5750,tribromoethanol,186,ANALGESIC AGENT,5.0,10.0
4176,p7c3,186,NAMPT INHIBITOR,2.0,7.0
2663,guanidinoethyldisulfide-bicarbonate,186,NITRIC OXIDE SYNTHASE INHIBITOR,3.0,13.0
1788,dexmedetomidine,186,ADRENERGIC RECEPTOR AGONIST,0.0,6.0
2148,estradiol-3-o-sulfamate,187,STERYL SULFATASE INHIBITOR,2.0,7.0
1675,daminozide,187,KDM2A INHIBITOR,1.0,7.0
5079,sd-2590,187,MATRIX METALLOPROTEASE INHIBITOR,4.0,8.0
4361,pf-514273,187,CANNABINOID RECEPTOR ANTAGONIST,1.0,8.0
999,bq-788,187,ENDOTHELIN RECEPTOR ANTAGONIST,2.0,4.0
432,aminosalicylate,187,CYCLOOXYGENASE INHIBITOR,1.0,2.0
434,aminosalicylate,187,CYCLOOXYGENASE INHIBITOR,1.0,2.0
433,aminosalicylate,187,CYCLOOXYGENASE INHIBITOR,1.0,2.0
3254,liquiritin,188,ANTIOXIDANT,1.0,6.0
2736,hoku-81,188,BRONCHODILATOR,2.0,6.0
2514,gepotidacin,188,TOPOISOMERASE INHIBITOR,2.0,6.0
4774,resmetirom,188,THYROID HORMONE RECEPTOR AGONIST,2.0,7.0
2638,gsk356278,188,PHOSPHODIESTERASE INHIBITOR,3.0,4.0
1270,cenerimod,188,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,1.0,3.0
5998,vu0360172,189,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,1.0,7.0
73,3-matida,189,GLUTAMATE RECEPTOR ANTAGONIST,1.0,3.0
6084,y-29794,189,PROLYL ENDOPEPTIDASE INHIBITOR,2.0,11.0
657,az-10606120,189,PURINERGIC RECEPTOR ANTAGONIST,1.0,3.0
501,anthraquinone,189,CDC INHIBITOR,0.0,5.0
5458,tc-g-1004,189,ADENOSINE RECEPTOR ANTAGONIST,1.0,6.0
2014,eipa,189,"SODIUM/HYDROGEN EXCHANGER INHIBITOR, TRANSIENT RECEPTOR POTENTIAL POLYCYSTIC INHIBITOR",11.0,20.0
3031,jph203,190,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,3.0,15.0
2286,ferroquine,190,ANTIMALARIAL AGENT,7.0,16.0
5858,uki-1,190,UROKINASE INHIBITOR,2.0,6.0
2121,eravacycline,191,ANTIBACTERIAL,145.0,280.0
3334,lxs196,191,PKC INHIBITOR,11.0,21.0
1214,ccmq,191,HOMOQUINOLINIC ACID BINDING INHIBITOR,2.0,9.0
187,abx464,192,ANTIVIRAL,6.0,21.0
3870,nhi-2,192,LACTATE DEHYDROGENASE INHIBITOR,1.0,4.0
3520,methanesulfonyl-fluoride,192,ACETYLCHOLINESTERASE INHIBITOR,2.0,10.0
389,amcasertib,193,KINASE INHIBITOR,10.0,21.0
722,azd9056,193,PURINERGIC RECEPTOR ANTAGONIST,2.0,5.0
1136,calhex-231,193,CALCIUM SENSING RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,2.0,8.0
2290,fevipiprant,193,PROSTAGLANDIN INHIBITOR,1.0,5.0
5485,tcs-3035,194,G PROTEIN-COUPLED RECEPTOR AGONIST,1.0,4.0
1000,bqu57,195,RAS GTPASE INHIBITOR,3.0,6.0
2711,hc-067047,195,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,9.0,15.0
4945,s-17092,195,PROLYL ENDOPEPTIDASE INHIBITOR,2.0,10.0
5572,tetrazol-5-yl-glycine-(rs),195,GLUTAMATE RECEPTOR AGONIST,1.0,3.0
3034,jte-013,195,LYSOPHOSPHOLIPID RECEPTOR ANTAGONIST,3.0,6.0
1406,cim-0216,195,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,3.0,12.0
4507,pk-44,196,DIPEPTIDYL PEPTIDASE INHIBITOR,1.0,3.0
5276,ssr240612,196,BRADYKININ RECEPTOR ANTAGONIST,2.0,5.0
4974,salvianolic-acid-a,196,MATRIX METALLOPROTEASE INHIBITOR,0.0,7.0
4803,ridinilazole,196,ANTIBACTERIAL,4.0,7.0
4553,pradefovir,196,CYTOCHROME P450 ACTIVATOR,0.0,4.0
541,aramchol,196,STEAROYL-COA DESATURASE INHIBITOR,4.0,9.0
1546,"cp-105,696",196,LEUKOTRIENE RECEPTOR ANTAGONIST,0.0,6.0
2252,fantofarone,196,CALCIUM CHANNEL BLOCKER,0.0,3.0
982,bms-986195,196,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,3.0,8.0
1125,cadazolid,196,ANTIBACTERIAL,2.0,8.0
5855,uk-356618,197,METALLOPROTEINASE INHIBITOR,5.0,8.0
3026,jnj-64619178,197,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,206.0,374.0
2653,guadecitabine,197,DNA METHYLTRANSFERASE INHIBITOR,261.0,454.0
77,3po,197,PHOSPHOFRUCTOKINASE INHIBITOR,4.0,10.0
3626,mk-0557,197,NEUROPEPTIDE RECEPTOR ANTAGONIST,3.0,8.0
2046,emiglitate,198,ALPHA GLUCOSIDE INHIBITOR,0.0,4.0
5851,udenafil,198,PHOSPHODIESTERASE INHIBITOR,2.0,10.0
1204,cbl0137,199,HISTONE CHAPERONE INHIBITOR,888.0,890.0
1567,cpi-169,199,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,19.0,50.0
1528,convallatoxin,199,CARDIAC GLYCOSIDE,888.0,890.0
5517,temefos,199,CHOLINESTERASE INHIBITOR,4.0,13.0
5390,tak-243,199,UBIQUITIN ACTIVATING ENZYME INHIBITOR,882.0,886.0
